{"public_id":"cl_2b66116bacfca9f627e3df682a22044f","status":"active","superseded_by_public_id":null,"corpus_id":21849769,"text":"Risk of the primary aggregate end point increases across albumin/creatinine ratio quartiles, with a significant trend beginning below the microalbuminuria threshold.","confidence":0.98,"paper":{"corpus_id":21849769,"title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.","url":"https://sah.borca.ai/papers/21849769"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0631daee3647f2adcfd880a037fec933","name":"microalbuminuria","description":"A low but abnormal level of albumin in urine, used here as a baseline exposure category.","types":["biomarker"],"url":"https://sah.borca.ai/concepts/co_0631daee3647f2adcfd880a037fec933"},{"public_id":"co_8a954ff5f0fb191141cc3731e4eec20c","name":"albumin/creatinine ratio","description":"The urine albumin-to-creatinine ratio measured at baseline as an index of albuminuria.","types":["measurement"],"url":"https://sah.borca.ai/concepts/co_8a954ff5f0fb191141cc3731e4eec20c"},{"public_id":"co_e40901f912a26e58875b99aa03b7e437","name":"primary aggregate end point","description":"The composite cardiovascular outcome analyzed across albumin/creatinine ratio quartiles.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_e40901f912a26e58875b99aa03b7e437"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_2b66116bacfca9f627e3df682a22044f"}